# Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients

> **NCT02145260** · NA · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 144 (actual)

## Conditions studied

- Intra-dialytic Hypotension

## Interventions

- **DRUG:** Lower dialysate sodium (138 mmol/L; using Renasol hemodialysis concentrate)
- **DRUG:** Higher dialysate sodium (142 mmol/L; using Renasol hemodialysis concentrate)

## Key facts

- **NCT ID:** NCT02145260
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-05-03
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2022-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145260, "Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02145260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*